Skip to search.
 FTSE 100 Down 0.29%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
7.56 5 Mar 21:00
Add to Portfolio
Prev Close:7.56
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:21.40
Beta:3.81
Earnings Date:16 Mar - 20 Mar (Est.)
Day's Range:N/A - N/A
52wk Range:6.33 - 15.56
Volume:0
Avg Vol (3m):659,353
Market Cap:458.07m
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INO 0.00%458.07m
AZN86.11b
PFE211.26b
SNY127.26b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.61
Quarterly EPS Est (Dec-14) :-0.10
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback